Technical Analysis for ACHV - Achieve Life Sciences, Inc.

Grade Last Price % Change Price Change
C 10.2 -2.30% -0.24
ACHV closed down 8.82 percent on Thursday, March 4, 2021, on 49 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 11
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical ACHV trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish -4.31%
180 Bearish Setup Bearish Swing Setup -4.31%
Lower Bollinger Band Walk Weakness -4.31%
Wide Bands Range Expansion -4.31%
Lower Bollinger Band Touch Weakness -4.31%
Oversold Stochastic Weakness -4.31%
MACD Bearish Centerline Cross Bearish -12.75%
50 DMA Support Bullish -12.75%
Hammer Candlestick Bullish -12.75%
Wide Bands Range Expansion -12.75%
Older End-of-Day Signals for ACHV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Support about 2 hours ago
Fell Below 200 DMA about 2 hours ago
Down 10% about 2 hours ago
Down 1 ATR about 2 hours ago
60 Minute Opening Range Breakdown about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Cancers Breast Cancer Prostate Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Non Small Cell Lung Cancer Oncolytics Biotech Apatorsen Clusterin

Is ACHV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.26
52 Week Low 4.514
Average Volume 342,465
200-Day Moving Average 9.41
50-Day Moving Average 11.26
20-Day Moving Average 13.34
10-Day Moving Average 12.12
Average True Range 1.14
ADX 34.16
+DI 15.93
-DI 31.53
Chandelier Exit (Long, 3 ATRs ) 12.68
Chandelier Exit (Short, 3 ATRs ) 13.57
Upper Bollinger Band 16.38
Lower Bollinger Band 10.30
Percent B (%b) 0.02
BandWidth 45.57
MACD Line -0.20
MACD Signal Line 0.33
MACD Histogram -0.5278
Fundamentals Value
Market Cap 37.45 Million
Num Shares 3.59 Million
EPS -2.61
Price-to-Earnings (P/E) Ratio -4.01
Price-to-Sales 0.00
Price-to-Book 1.21
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.42
Resistance 3 (R3) 12.54 12.01 12.09
Resistance 2 (R2) 12.01 11.50 11.94 11.98
Resistance 1 (R1) 11.22 11.19 10.96 11.10 11.87
Pivot Point 10.69 10.69 10.55 10.63 10.69
Support 1 (S1) 9.90 10.18 9.64 9.78 9.01
Support 2 (S2) 9.37 9.87 9.31 8.90
Support 3 (S3) 8.58 9.37 8.79
Support 4 (S4) 8.46